Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464087
Status:
COMPLETED
Last Update Posted:
2013-08-01
First Post:
2007-04-19
Brief Title:
Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI
Sponsor:
Medstar Health Research Institute
Organization:
Medstar Health Research Institute
Organization Data
Organization:
Medstar Health Research Institute
Class:
OTHER
Study ID:
SWITCH III
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medstar Health Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |